Nuclear medicine studies in the dialysis patient

Seminars in Dialysis

Volumn 15, Issue 4, 2002, Pages 269-276

  Meller, Johannes ^a   Sahlmann, Carsten O ^a   Becker, Wolfgang ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

SUCCIMER TC 99M;

ADULT; CHILD; CHRONIC KIDNEY FAILURE; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; KIDNEY FUNCTION TEST; MALE; METHODOLOGY; NUCLEAR MEDICINE; PERITONEAL DIALYSIS; REVIEW; RISK ASSESSMENT; SCINTISCANNING; SENSITIVITY AND SPECIFICITY;

ADULT; CHILD; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; NUCLEAR MEDICINE; PERITONEAL DIALYSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; TECHNETIUM TC 99M DIMERCAPTOSUCCINIC ACID;

EID: 0036652939     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1046/j.1525-139X.2002.00069.x     Document Type: Review

References (60)

1. Sapirstein LA, Vidt DG, Mandel MJ, Hanusek G: Volumes of distribution and clearances of intravenously injected creatinine in the dog. Am J Physiol 181:330-336, 1955
2. Blaufox MD, Merrill JP: Simplified hippuran clearance. Measurement of renal function in man with simplified hippuran clearances. Nephron 3:274-281, 1966
3. 51Cr-EDTA. Clin Sci 37:169-180, 1969
4. Oberhausen E, Kirsch W, Emrani I: Measurement of unilateral renal plasma flow by combination of clearance determination and renograms. In: Blaufox MD, Funck-Brentano JL, eds. Radionuclides in Nephrology. New York: Grune & Stratton, 1972:233-239
5. Rohlof R, Hast B, Leisner B, Heinze HG: Bestimmung der 1-131-Hippuranclearance im Rahmen der kammerafunktionsszintigraphie nach vereinfachten Modifikationen der Methode von Oberhansen. Nuklearmedizin 13:303-120, 1974
6. Daley JJ, Jones WA, Rudd TG, Tremann JA: Differential 99mTc dimercaptosuccinic acid (DMSA) renal localization: correlations with renal function. J Nucl Med 18:594-595, 1977
7. Rushton HG, Majd M: Dimercaptosuccinic acid renal scintigraphy for the evaluation of pyelonephritis and scarring: a review of experimental and clinical studies. J Urol 148:1726-1712, 1992
8. Meller J, Zappel H, Becker W: Indikationen für die Szintigraphie mit 99mTc-Dimercaptosuccinid in der Pädiatrie Nuklearmediziner 23:237-254, 2000
9. Jakobsson B, Berg U, Svensson L: Renal scarring after acute pyelonephritis. Arch Dis Child 70:111-115, 1994
10. Merrick MV, Notghi A, Chalmers N, Wilkinson AG, Uttley WS: Long term follow up to determine the prognostic value of imaging after urinary tract infections. Part 2: scarring. Arch Dis Child 72:393 -396, 1995
11. Majd M, Rushton HG, Jantausch B, Wiedermann BL: Relationship among vesicoureteral reflux, P-fimbriated Escherichia coli. and acute pyelonephritis in children with febrile urinary tract infection. J Pediatr 119:578 585, 1991
12. Goldraich NP, Ramos OL, Goldraich HH: Urography versus DMSA scan in children with vesicoureteric reflux. Pediatr Nephrol 3:1-51, 1989
13. Shanon A, Feldman W, McDonald P, Martin DJ, Matzinger MA, Shillinger J, McLaine PN, Wolfish N: Evaluation of renal scars by technetium-labeled dimercaptosuccinic acid scan, intravenous urography, and ultrasonography: a comparative study. J Pediatr 120:399-403, 1992
14. Tasker AD, Lindsell DR, Moncrieff M: Can ultrasound reliably detect renal scarring in children with urinary tract infection? Clin Radiol 47:177-179, 1993
15. Mucci B, Maguire B: Does routine ultrasound have a role in the investigation of children with urinary tract infection? Clin Radiol 49:324-325, 1994
16. 99mTc MAG3(99mTc mercaptoacetylglycylglycine). Nucl Med Biol 15:109-118, 1988
17. Paul R, Kiiliainen H, Tarssanen L, Vorne M: [99Tcm]MAG3 gamma camera nephrography in epidemic nephritis. Nucl Med Commun 12:15-25, 1991
18. Sfakianakis GN, Carmona AJ, Sharma A, Strauss J, Georgiou MF, Zilleruelo GE, Abitbol CA, Montane BS: Diuretic MAG3 scintirenography in children with HIV nephropathy: diffuse parenchymal dysfunction. J Nucl Med 41:1037-1042, 2000
19. Tezuka M, Murata Y, Ishida R, Sawada Y, Shibuya H: Tc-99m DTPA renography in patients with collagen disease. Clin Nucl Med 26:187-192, 2001
20. Canivet E, Lavaud S, Wampach H, Wuillai A, Randoux C, Liehn JC, Chanard J: Detection of subclinical abdominal hernia by peritoneal scintigraphy. Adv Perit Dial 16:16104-16107, 2000
21. Goh AS, Lee GS, Kee SG, Ang ES, Stern Castell O, Sundram FX: Radionuclide detection of dialysate leakage in patients on continuous ambulatory peritoneal dialysis. Ann Acad Med Singapore 23:315-318, 1994
22. Juergensen PH, Rizvi H, Caride VJ, Kliger AS, Finkelstein FO: Value of scintigraphy in chronic peritoneal dialysis patients. Kidney Int 55:1111-1119, 1999
23. Kopecky RT, Frymoyer PA, Witanowski LS, Thomas FD: Complications of continuous ambulatory peritoneal dialysis: diagnostic value of peritoneal scintigraphy. Am J Kidney Dis 10:123-132, 1987
24. Kopecky RT, Frymoyer PA, Witanowski LS, Thomas FD, Wojtaszek J, Reinitz ER: Prospective peritoneal scintigraphy in patients beginning continuous ambulatory peritoneal dialysis. Am J Kidney Dis 15:228-236, 1990
25. Meller J, Becker W: Nuklearmedizinische Diagnostik bei Patenten mit Fieber unklarer Genese (FUO). Nuklearmedizin 40:59-70, 2001
26. Becker W: The contribution of nuclear medicine to the patient with infection. Eur J Nucl Med 22:1195-1211, 1995
27. Palestro CJ, Vega A, Kim CK, Vallabhajosula S, Goldsmith SJ: Indium-111-labeled leukocyte scintigraphy in hemodialysis access-site infection. J Nucl Med 31:319 324, 1990
28. Ayus JC, Sheikh-Hamad D: Silent infection in clotted hemodialysis access grafts. Am Soc Nephrol 9:1314-1317, 1998
29. Kipper SL, Steiner RW, Witztum KF, Basarab RM, Kipper MS, Halpem SE, Ashburn WL: In-111-leukocyte scintigraphy for detection of infection associated with peritoneal dialysis catheters. Radiology 151:491-494, 1984
30. Becker W, Götz R, Heidbreder E, Börner W: Indium-111 white blood cell scan in the diagnosis of infectious complications in patients undergoing regular dialysis treatment. In: Bischof-Delaloye A, Blaufox MD, eds Contributions to Nephrology, vol. 56. Basel: Karger, 1987:191-195
31. Leithner C, Sinzinger H, Pohanka E, Schwarz M, Syre G: III-Indium-labeled thrombocytes in the diagnosis of acute kidney transplant rejections and in monitoring the therapy of rejection reactions with prostacyclin. Wien Klin Wochenschr 96:112-117, 1984
32. Fuster D, Lomena F, Torregrosa JV, Oppenheimer F, Piera C, Setoain FJ, Lateral C, Herranz R, Setoain J: Indium-111 labelled platelet scintigraphy can predict the immunological origin of fever in patients on dialysis carrying a non-functioning renal allograft. Eur J Nucl Med 27:314-318, 2000
33. 111In-labelled platelets for assessment of thrombogenicity of new haemodialysis vascular access. Nucl Med Commun 20:445-451, 1999
34. McAfee JG: Radionuclide imaging in metabolic and systemic skeletal diseases. Semin Nucl Med 16:344 349, 1987
35. Ryan PJ, Fogelman I: Bone scintigraphy in metabolic bone disease. Semin Nucl Med 27:291-305, 1997
36. Coolens JL, Devos P, De-Roo M: Diffuse pulmonary uptake of 99mTc bone-imaging agents: case report and survey. Eur J Nucl Med 11:36-42, 1985
37. Yeo E, Miller JH: Pulmonary gallium-67 uptake in diffuse pulmonary calcinosis. Pediatr Radiol 26:825-826, 1996
38. Cesani F, Villanueva-Meyer J: Intense myocardial and lung uptake of 99m-Tc-pyrophosphate using single photon emission computed tomography in a patient with end-stage renal disease and secondary hyperparathyroidism. Int Urol Nephrol 28:569-574, 1996
39. Reeve TS, Babidge WJ, Parkyn RF, Edis AJ, Delbridge LW, Devitt PG, Maddern GJ: Minimally invasive surgery for primary hyperparathyroidism: systematic review. Arch Surg 135:481-487, 2000
40. 99mTc sestamibi parathyroid scintigraphy. In: Freeman LM, ed. Nuclear Medicine Annual 1995. New York: Raven Press, 1995:51-79
41. 123I/99mTc-sestamibi subtraction single photon emission computed tomography. J Clin Endocrinol Merab 83:3867-3871, 1998
42. Neumann DR, Esselstyn CB Jr, Madera AM: Sestamibi/iodine subtraction single photon emission computed tomography in reoperative secondary hyperparathyroidism. Surgery 128:22-28, 2000
43. Kurata C, Uehara A, Sugi T, Ishikawa A, Fujita K, Yonemura K, Hishida A, Ishikawa K, Tawarahara K, Shouda S, Mikami T: Cardiac autonomic neuropathy in patients with chronic renal failure on hemodialysis. Nephron 84:312-319, 2000
44. 123I-labeled metaiodobenzylguanidine in patients with chronic renal failure and autonomic dysfunction. J Nucl Cardiol 3:508-515, 1996
45. Dac MW, Randall RJ, Ursell PC, Chin MC, BA, Stillson CA, Moise NS: Heterogeneous sympathetic innervation in German shepherd dogs with inherited ventricular arrhythmia and sudden cardiac death. Circulation 96:1337-1342, 1997
46. Floege J, Ketteler M: Beta2-microglobulin-derived amyloidosis: an update. Kidney Int 59(suppl 78):S164-S171, 2001
47. 2- microglobulin amyloidosis). Nephrol Dial Transplant 16(suppl 4):12-16, 2001
48. Yen TC, Tzen KY, Chen KS, Tsai CJ: The value of gallium-67 and thallium-201 whole-body and single-photon emission tomography images in dialysis-related beta 2-microglobulin amyloid. Eur J Nucl Med 7:56-61, 2000
49. Tan SY, Baillod R, Brown E, Farrington K, Soper C, Percy M, Clutterbuck E, Madhoo S, Pepys MB, Hawkins PN: Clinical, radiological and serum amyloid P component scintigraphic features of beta2-microglobulin amyloidosis associated with continuous ambulatory peritoneal dialysis. Nephrol Dial Tramplant 14:1467-1471, 1999
50. Hawkins PN, Aprile C, Capri G, Vigano L, Munzone E, Gianni L, Pepys MB, Merlini G: Scintigraphic imaging and turnover studies with iodine-131 labelled serum amyloid P component in systemic amyloidosis. Eur. J Nucl Med 25:701-708, 1998
51. Kao CH, Hsieh JF, Tsai SC, Ho YJ, Chang HR: Decreased salivary function in patients with end-stage renal disease requiring hemodialysis. Am J Kidney Dis 36:1110-1114, 2000
52. Ross EA, Koo LC: Improved nutrition after the detection and treatment of occult gastroparesis in nondiabetic dialysis patients. Am J Kidney Dis 31:62-66, 1998
53. Kao CH, Hsu YH, Wang SJ: Delayed gastric emptying in patients with chronic renal failure. Nucl Med Commun 17:164-167, 1996
54. Mello AM, Isaacs R, Petersen J, Kronenberger S, McDougall R: Management of thyroid papillary carcinoma with radioiodine in a patient with end stage renal disease on hemodialysis. Clin Nucl Med 19:776-781, 1994
55. 131I treatment of thyroid papillary carcinoma in a patient with renal failure. Cancer 66:2509-2513, 1990
56. 131I by hemodialysis. Clin Nephrol 38:110-114, 1992
57. Gardner DF, Mars DR, Thomas RG, Bumrungsup C, Misbin RI: Iodine retention and thyroid dysfunction in patients on hemodialysis and continuous ambulatory peritoneal dialysis. Am J Kidney Dis 7:471-476, 1986
58. Toubert ME, Michel C, Metivier F, Peker MC, Rain JD: Iodine-131 ablation therapy for a patient receiving peritoneal dialysis. Clin Nucl Med 26:302-305, 2001
59. Kaptein EM, Levenson H, Siegel ME, Gadallah M, Akmal M: Radioiodine dosimetry in patients with end-stage renal disease receiving continuous ambulatory peritoneal dialysis therapy. J Clin Endocrinol Metab 85:3058-3064, 2000
60. Oddie TH, Flanigan WJ, Fisher DA: Iodine and thyroxine metabolism in anephric patients receiving chronic peritoneal dialysis. J Clin Endocrinol Metab 31:277-282, 1970